Cambridge Catalogue  
  • Help
Home > Catalogue > Color Atlas of Vascular Tumors and Vascular Malformations
Color Atlas of Vascular Tumors and Vascular Malformations
Google Book Search

Search this book

Details

  • 400 colour illus.
  • Page extent: 310 pages
  • Size: 279 x 215 mm
  • Weight: 1.23 kg

Hardback

 (ISBN-13: 9780521848510)

Color Atlas of Vascular Tumors and Vascular Malformations
Cambridge University Press
978-0-521-84851-0 - Color Atlas of Vascular Tumors and Vascular Malformations - by Odile Enjolras
Index

Index




Aagenaes syndrome 228

acrylic polymers

cf. Ethibloc®, 172

VM 172–3

Adams-Oliver syndrome 8, 134

AKC; see angiokeratoma circumscriptum

amyotrophy, VM 194

Anderson-Fabry disease, angiokeratoma corporis diffusum 136

anetoderma, IH 39

angio-CT scans 6

angioblastoma of Nakagawa; see tufted angioma

angiogenesis-dependent vascular anomalies, pathogenesis 9

angiography 6

IH 24

angiokeratoma circumscriptum (AKC) 158–9

angiokeratoma corporis diffusum 160

Anderson-Fabry disease 136

angiokeratomas 135–6

Fordyce 159

angioma, nomenclature 3

angioma serpiginosum of Hutchinson 160

ankle

KMP 114

RICH 94

arm

IH 38, 40, 49

NICH 96

PWS 151

RICH 91–2

VM 195–6

arterial superselective embolization 7

arteriovenous fistulas (AVF), Rendu-Osler-Weber syndrome (HHT) 259

arteriovenous malformations (AVM) 255–84

clinical features 255–6

CM-AVM syndrome 260

common 255–8

Cowden syndrome 260

CT angiography 257

CT scanning 257

digital arteriography 257

ear 265–6

Ehlers-Danlos type IV syndrome 260

eye 275

face 266, 278–9, 281

foot 275

FPDL 264

hand 268–9, 273, 274

investigations 263–84

leg 269–70, 272

MRA 257

MRI 257

overview 255

Parkes Weber syndrome 270–1

parotid area 280

pathology 261–2

problems created 263–84

pseudo Kaposi sarcoma skin changes 269, 272

pulsed Doppler 256

radiological investigations 256–7

Rendu-Osler-Weber syndrome (HHT) 259

scalp 267, 274

Schobinger staging 256, 263, 282

specific locations 263–84

stage III 276–7

syndromic 258–60

treatment 257–8, 263–84

ultrasonography/Doppler 256

aspirin

KMP 113, 118, 120

telangiectasia 118

ataxia telangiectasia (AT) 8, 10, 135

neurological risks 129

AVF; see arteriovenous fistulas

AVM; see arteriovenous malformations

back, KMP 115–16

Bannayan-Riley-Ruvalcaba syndrome 8, 10

Bean (blue rubber bleb nevus) syndrome 8, 173–4

clinical aspects 211–12

pathology

‘beard’ infantile hemangioma 53

benign lymphangioendothelioma 232, 246

biopsy 6

IH 24

birthmark, nomenclature 3

bleomycin treatment, IH 28

blue rubber bleb naevus (BRBN) syndrome 8, 173–4

clinical aspects 211–12

pathology

Bonnet-Dechaume-Blanc syndrome 258

MRI 283

neurological risks 129

brain anomalies, SWS 148

BRBN; see blue rubber bleb naevus

breast, IH 49

buttocks

IH 50–1, 60

KHE 112

capillary hemangioma; see infantile hemangioma

capillary malformations (CM) 125–32

Adams-Oliver syndrome 8, 134

angiokeratomas 135–6

associations 127–8

AT 135

clinical aspects

CM-AVM syndrome 10, 260

CMTC 133

EAH 127

Ethibloc® 157

face 163

KTS 129–31

lumbar 151

macrocephaly-cutis marmorata syndrome 134

neurological risks 129

nevus anemicus 149

overview 125

pathology 137–9

PPV 127, 149

proteiform syndromes 131–3

Proteus syndrome 131–3

PWS 125–7, 140

pyogenic granulomas 162

Rendu-Osler-Weber syndrome (HHT) 8, 10, 134–5

reticulate diffuse CM 134, 157

spina-lipoma, attached cord 151

spinal cord, attached syringomyelia 150

SWS 128–9

syndromic 128–33

telangiectasia 133–5

thigh 140

cardiac assessment, PHACE(S) syndrome 57

causes

IH 8–9, 21–2

vascular malformations 8–9

cavernous hemangioma; see infantile hemangioma

cephalic area

IH 26, 41

neurological risks 129

cephalic VM

clinical patterns 181

neurological risks 129

cerebral cavernous malformations 10

cerebral developmental venous anomaly (DVA) 191

cholestasis-lymphedema syndrome 228

classification, “biological” 4

fast-flow vascular malformations 4

slow-flow vascular malformations 4

classification, ISSVA 3–10

fast-flow vascular malformations 6

molecular biology 9

slow-flow vascular malformations 6

updated 6

vascular malformations 6

vascular tumors 6

CM-AVM syndrome 10, 260

CM; see capillary malformations

CMTC; see cutis marmorata telangiectatica congenita

CMVM; see cutaneous and mucosal venous malformations

Cobb syndrome 258

computed tomography (CT) 6, 16

AVM 257

CT angiography, AVM 257

IH 24, 56

LM 226

VM 170

conclusion 287–90

congenital hemangiomas 78

features 78–80

missing links 82, 96

NICH 81–2

RICH 80–2

conventional vascular imaging 17

conventional X-rays 15

corticosteroid, topical, IH 27

Cowden syndrome, AVM 260

cryosurgery

see also surgical excision/resection

IH 25

CT; see computed tomography

cutaneous and mucosal venous malformations (CMVM), familial 10, 174

cutis marmorata-macrocephaly syndrome 8, 134, 156

neurological risks 129

cutis marmorata telangiectatica congenita (CMTC) 8, 133, 156

developmental venous anomaly (DVA), cerebral 191

diagnostic imaging devices 13

IH 6, 24

vascular malformations 6

vascular tumors 6

diffuse reticulate CM 134, 157

digital arteriography, AVM 257

digital computed arteriogram, VM 170

direct puncture sclerotherapy 7

LM 226, 251

disseminated neonatal hemangiomatosis (DNH), IH 22, 55

DNH; see disseminated neonatal hemangiomatosis

Doppler

see also ultrasonography/Doppler

pulsed Doppler 256

DVA; see cerebral developmental venous anomaly (DVA)

dyspnea

IH 54

laryngeal 66–7

VM 201

EAH; see eccrine angiomatous hamartoma

ear

AVM 265–6

IH 56, 70–1

RICH 98

eccrine angiomatous hamartoma (EAH) 127, 160–1

Ehlers-Danlos type IV syndrome, AVM 260

elastic garments, VM 192, 195–6

embolization, IH 25

endoscopy, IH 26

endothelial cells, markers 7–8

epilepsy, SWS 128–9, 141

ethanol, VM 200, 203–4

Ethibloc®

cf. acrylic polymers 172

CM 157

LM 248, 252

VM 202, 205, 206

evanescent (or fading) macule, clinical aspects 140–1

eye

AVM 275

IH 44–6, 57, 61–3, 65, 68–9

LM 225, 235, 246

PHACE(S) syndrome 57

TA 110

VM 183, 190, 207

face

AVM 266, 278–9, 281

CM 163

FPDL 163

IH 42, 58, 59, 64, 71

KMP 116, 117

LM 236

PWS 143–7

RICH 98

VM 206

fading (or evanescent) macule, clinical aspects 140–1

familial cutaneous and mucosal venous malformations (CMVM) 10, 174

fast-flow vascular malformations

classification, “biological” 4

classification, ISSVA 6

fingers, VM 193

flashlamp pumped-pulsed dye laser

AVM 264

CM 163

face 163

PWS 126–7

foot, AVM 275

Fordyce angiokeratomas 159

forearm/hand, IH 40, 67

FPDL; see flashlamp pumped-pulsed dye laser

genetic defects

see also inherited vascular malformations

IH 24

vascular malformations 10

genitalia, VM 194–5

glomuvenous malformations (GVM) 174–5

clinical aspects 216–18

glomangioma 10

pathology

glucocorticosteroid (GS) treatment, IH 25–7, 61, 65, 67

Gorham-Stout syndrome 8

Gorham syndrome 228

growth

hemangiomas 8–9

IH 3, 8, 35–7

vascular malformations 3–4

vascular tumors 3

GS treatment; see glucocorticosteroid treatment

GVM; see glomuvenous malformations

hand

AVM 268–9, 273, 274

IH; see forearm/hand

KHE 111

VM 193

hearing tests, IH 26

hemangiomas

see also infantile hemangioma

characteristics 7–9

growth 8–9

nomenclature 3

pathogenesis 8

regression 7

hemarthrosis, VM 200

Hennekam syndrome 228

hereditary hemorrhagic telangiectasia (HHT); see Rendu-Osler-Weber syndrome

HHT; see Rendu-Osler-Weber syndrome

Hutchinson angioma serpiginosum 135

IFN; see interferon alpha 2a or 2b

IH; see infantile hemangioma

imaging; see diagnostic imaging devices

immature hemangioma; see infantile hemangioma

incidence, IH 21

infantile hemangioma (IH) 21–6

anetoderma 39

angiography 24

arm 38, 40, 49

‘beard’, 53

biopsy 24

bleomycin treatment 28

breast 49

buttocks 50–1, 60

causes 8–9, 21–2

cephalic area 26, 41

clinical aspects 35–72

clinical examination 26

corticosteroid, topical 27

cryosurgery 25

CT scanning 24, 56

diagnosis 24

diagnostic imaging devices 6, 24

DNH 22, 55

dyspnea 54

ear 56, 70–1

embolization 25

endoscopy 26

eye 44–6, 57, 61–3, 65, 68–9

face 42, 58, 59, 64, 71

forearm/hand 38, 40, 67

genetic defects 24

glucocorticosteroid (GS) treatment 25–7, 61, 65, 67

growth 3, 8, 35–7

hearing tests 26

IFN 27–8, 62, 64, 66–7

incidence 21

intralesional glucocorticosteroid 27

investigations 35–72

laryngeal dyspnea 66–7

lasers 25

lips 47, 52, 72

mesenchymal stem cells 40

MRI 24, 26, 43, 56

nerves 40

neurological risks 129

cf. NICH 79

nomenclature 21

nose 48, 70

ophthalmological examination 26, 44–6, 57

oral glucocorticosteroid (GS) treatment 25–7, 65

parotid hemangioma 70–1

pathology 24–5, 30–4

PHACE(S) syndrome 23–4, 57, 58, 62

phases 22, 38

precursors 36–7, 58

radiotherapy 25

regression 22, 38, 39

cf. RICH 79

scalp 38

shoulder 39

sternal fusion defects 58

subcategories 22

surgical excision/resection 28–9

thorax 49, 58

topical corticosteroid 27

treatment 25–9, 35–72

ulceration 40, 49–52, 70–1

ultrasonography/Doppler 24, 26, 43

cf. vascular malformations 5

VCR 28, 66–7

X-linked defect 24

inherited vascular malformations 9

see also genetic defects

interferon alpha 2a or 2b (IFN), IH 27–8, 62, 64, 66–7

intralesional bleomycin treatment, IH 28

intralesional glucocorticosteroid, IH 27

investigations, IH 35–72

investigations tools 13

see also diagnostic imaging devices

kaposiform hemangioendothelioma (KHE) 102

buttocks 112

hand 111

KMP 102, 112

leg 111

LM 111

pathology 107–8

TA 112

treatment 102

Kasabach-Merritt phenomenon (KMP) 102–5, 112–20

ankle 114

aspirin 113, 118, 120

back 115–16

face 116, 117

KHE 102, 112

cf. LIC 171

neck 115–16, 119

nosology 103

pentoxyfillin 113

platelet infusions 116

presentation differences 113–14

TA 101, 102, 109, 112

telangiectasia 120

thorax 120

thrombocytopenia 115–16, 120

ticlopidine 113, 118, 120

treatment 103–4

VCR 112, 115–17, 119

Kasabach-Merritt syndrome (KMS) 102–3

cf. LIC 171

KHE; see kaposiform hemangioendothelioma (KHE)

Klippel-Trenaunay syndrome (KTS) 8, 129–31

clinical characteristics 130, 259

leg 152, 153

thigh 152, 153

KMP; see Kasabach-Merritt phenomenon

KMS; see Kasabach-Merritt syndrome

knee

RICH 87–8, 90

VM 198, 206

KTS; see Klippel-Trenaunay syndrome

laryngeal dyspnea, IH 66–7

lasers 7

FPDL 126–7, 163, 264

IH 25

LM 227

PWS 162

leg

AVM 269–70, 272

KHE 111

KTS 152, 153

RICH 97

VM 198

LIC; see localized intravascular coagulopathy

lips

IH 47, 52, 72

LM 235

ulceration 52

VM 183, 203–4

LM; see lymphatic malformations

localized intravascular coagulopathy (LIC)

cf. KMP/KMS 171

VM 192, 200

lumbar CM 151

lymphangioma, nomenclature 3

lymphatic malformations (LM) 224–52

bony 225

clinical aspects 224

common 224–7

CT scanning 226

DIC 242

direct puncture 226, 251

Ethibloc® 248, 252

eye 225, 235, 246

face 236

investigations 226, 233–52

KHE 111

lasers 227

lips 235

macrocystic 224–6

mandible 237

microcystic 224, 225

mouth 236

MRI 226, 240–1, 245

neck 238, 244, 249–50

overview 224

pathology 230–2

pelvic 242–3

problems created 233–52

regression 226–7, 248

sclerotherapy 248

specific locations 233–52

surgical excision/resection 227

syndromic 227–9

treatment 226–7, 233–52

ultrasonography/Doppler 224, 226, 239

visceral 226

lymphedema 247

lymphedema of Milroy 10

lymphedemadistichiasis 10

lymphedemas, syndromic 227–8

lymphoscintigraphy 6

LYVE-1/CD 31 double staining 7

macrocephaly-cutis marmorata syndrome 8, 134, 156

neurological risks 129

macrocystic LM 224–6

Maffucci syndrome 8, 175–6

clinical aspects 221

pathology 219–20

magnetic resonance angiography (MRA) 6

AVM 257

magnetic resonance imaging (MRI) 6, 16–17

AVM 257

Bonnet-Dechaume-Blanc syndrome 283

IH 24, 26, 43, 56

LM 226, 240–1, 245

PWS 148

RICH 80

VM 169, 170, 189, 197

Wyburn-Mason syndrome 283

magnetic resonance venography (MRV) 6

mandible, LM 237

markers

endothelial cells 7–8

vascular tumors cf. vascular malformations 5

maxilla, PWS 144

mesenchymal stem cells, IH 40

microcystic LM 224, 225

missing links, congenital hemangiomas 82, 96

molecular biology, classification, ISSVA 9

mouth

LM 236

VM 182, 183, 186–9, 201–5, 208

MRA; see magnetic resonance angiography

MRI; see magnetic resonance imaging

MRV; see magnetic resonance venography

multifocal lymphangioendotheliomatosis 247

multiple miliary-type hemangiomas; see disseminated neonatal hemangiomatosis

neck

KMP 115–16, 119

LM 238, 244, 249–50

PWS 150

VM 184–6

nerves, IH 40

neurological risks, CM 129

nevus anemicus, CM 149

NICH; see Non-Involuting Congenital Hemangioma

nodular hyperplasia, PWS 143

nomenclature 3

angioma 3

birthmark 3

hemangioma 3

IH 21

lymphangioma 3

Non-Involuting Congenital Hemangioma (NICH) 81–2

arm 96

features

cf. IH 79

pathological features 99

pathology

cf. RICH 79

telangiectasia 95

nose, IH 48, 70

occipital RICH 93

ophthalmological examination

IH 26, 44–6, 57

PHACE(S) syndrome 57

oral glucocorticosteroid (GS) treatment, IH 25–7, 65

orbital LM, neurological risks 129

Parkes Weber syndrome 259

AVM 270–1

clinical characteristics 130, 259

parotid area, AVM 280

parotid hemangioma, IH 70–1

pathogenesis

angiogenesis-dependent vascular anomalies 9

hemangiomas 8

vascular malformations 9–10

(F)PDL; see flashlamp pumped-pulsed dye laser

pelvis, LM 242–3

pentoxyfillin

KMP 112

VCR 112

PHACE(S) syndrome

cardiac assessment 57

eye 57

IH 23–4, 57, 58, 62

ophthalmological examination 57

phakomatosis pigmentovascularis (PPV) 127, 149

pharmacological therapies 7

phlebography, VM 170–1

platelet infusions, KMP

port-wine stains (PWS) 125–7

arm 151

clinical aspects 125–6, 140, 142

diagnosis 126

dissemination 141

face 143–7

FPDL 126–7

lasers 162

maxilla 144

MRI 148

neck 150

nodular hyperplasia 143

proteiform syndromes 154–5

Proteus syndrome 154–5

regression 140

spinal cord, attached syringomyelia 150

tissular hyperplasia 144

treatment 126–7

PPV; see phakomatosis pigmentovascularis

precursors, IH 36–7, 58

pregnancy, telangiectasia 161

proteiform syndromes 131–3

PWS 154–5

Proteus syndrome 8, 131–3

diagnostic criteria 132

neurological risks 129

PWS 154–5

pseudo Kaposi sarcoma skin changes, AVM 269, 272

pulsed Doppler, AVM 256

PWS; see port-wine stains

pyogenic granulomas, CM 162

radiographs, plain 6

radiological investigations, AVM 256–7

radiological tools 13

see also diagnostic imaging devices

radiotherapy, IH 25

Rapidly Involuting Congenital Hemangioma (RICH) 80–2

ankle 94

arm 91–2

ear 98

face 98

features 80–1, 87–94

cf. IH 79

knee 87–8, 90

leg 97

management 81

MRI 80

cf. NICH 79

occipital 93

pathology 83–4

scalp 94, 97

thigh 97

ultrasonography/Doppler 80

regional cerebral blood flow (rCBF), SPECT 149

regression

hemangiomas 7

IH 22, 38, 39

LM 226–7, 248

PWS 140

TA 110

vascular malformations 4

vascular tumors 4

Rendu-Osler-Weber syndrome (HHT) 8, 10, 134–5, 157

AVF 259

AVM 259

neurological risks 129

reticulate diffuse CM 134, 157

RICH; see Rapidly Involuting Congenital Hemangioma

salmon patch, clinical aspects 140–1

scalp

AVM 267, 274

IH 38

RICH 94, 97

VM 190

Schobinger staging, AVM 256, 263, 282

shoulder

IH 39

VM 197

Single Photon Emission Computed Tomography (SPECT), rCBF 149

sleep apnea syndrome, VM 182

slow-flow vascular malformations 8

classification, “biological” 4

classification, ISSVA 6

SPECT; see Single Photon Emission Computed Tomography

spina-lipoma, attached cord, CM 151

spinal cord, attached syringomyelia, PWS 150

sternal fusion defects, IH 58

strawberry mark; see infantile hemangioma

Sturge-Weber syndrome (SWS) 128–9

brain anomalies 148

epilepsy 128–9, 141

neurological risks 129

surgical excision/resection 7

see also cryosurgery

IH 28–9

LM 227

SWS; see Sturge-Weber syndrome (SWS)

syndromes 8

syndromic AVM 258–60

syndromic CM 128–33

syndromic LM 227–9

syndromic lymphedemas 227–8

syndromic VM, nosology 173–6

syringomyelia, attached spinal cord, PWS 150

TA; see tufted angioma

telangiectasia 118, 133–5

see also Rendu-Osler-Weber syndrome

aspirin 118

KMP 120

NICH 95

pregnancy 161

syndromes with 133–5

ticlopidine 118

therapeutic strategies

see also treatment

vascular malformations 7

vascular tumors 7

thigh

KTS 152, 153

RICH 97

thorax

IH 49, 58

KMP 120

thrombocytopenia, KMP 115–16, 120

ticlopidine

KMP 113, 118, 120

telangiectasia 118

tissular hyperplasia, PWS 144

tongue, VM 183, 189

topical corticosteroid, IH 27

treatment

see also therapeutic strategies

AVM 257–8, 263–84

IH 25–9, 35–72

KHE 102

KMP 103–4

LM 226–7, 233–52

PWS 126–7

TA 101

vascular malformations 9–10

vascular tumors 9–10

VM –208, 172

tufted angioma (TA) 101

clinical aspects 109–20

eye 110

KHE 112

KMP 101, 102, 109, 112

pathology 105–6

regression 110

treatment 101

ulceration

IH 40, 49–52, 70–1

lips 52

ultrasonography/Doppler 6, 15

AVM 256

IH 24, 26, 43

LM 224, 226, 239

RICH 80

VM 169

updated classification, ISSVA 6

Van Lohuizen syndrome; see cutis marmorata telangiectatica congenita

vanishing bone syndrome 228

vascular anomalies; see vascular malformations; vascular tumors

vascular endothelial growth factor (VEGF), vascular tumors cf. vascular malformations 7

vascular imaging, conventional 17

vascular malformations

causes 8–9

classification, ISSVA 6

diagnostic imaging devices 6

fast-flow 4, 6

genetic defects 10

growth 3–4

cf. IH 5

inherited 9

pathogenesis 9–10

regression 4

slow-flow 8

subcategories 4–5

therapeutic strategies 7

treatment 9–10

cf. vascular tumors 3–10

vascular tumors

see also infantile hemangioma

classification, ISSVA 6

diagnostic imaging devices 6

growth 3

regression 4

therapeutic strategies 7

treatment 9–10

cf. vascular malformations 3–10

VCR; see vincristine (VCR)

VEGF; see vascular endothelial growth factor

venous malformations (VM) 168–71

acrylic polymers 172–3

amyotrophy 194

arm 195–6

cephalic area 181

clinical patterns 168–9, 181–208

common 168–73

CT scanning 170

digital computed arteriogram 170

DVA 191

dyspnea 201

elastic garments 192, 195–6

ethanol 200, 203–4

Ethibloc® 202, 205, 206

eye 183, 190, 207

face 206

fingers 193

genitalia 194–5

hand 193

hemarthrosis 200

investigations 169, 181–208

knee 198, 206

leg 198

LIC 192, 200

lips 183, 203–4

mouth 182, 183, 186–9, 201–5, 208

MRI 169, 170, 189, 197

neck 184–6

overview 168–9

pathology 169, 177–80

phlebography 170–1

scalp 190

shoulder 197

sleep apnea syndrome 182

syndromic, nosology 173–6

tongue 183, 189

treatment 172, 181–208

ultrasonography/Doppler 169

vincristine (VCR)

IH 66–7

KMP 112, 115–17, 119

VM; see venous malformations (VM)

Wyburn-Mason syndrome 258

MRI 283

neurological risks 129

X-linked defect, IH 24

X-rays, conventional 15


© Cambridge University Press
printer iconPrinter friendly version AddThis